Señales en vivo de 002550.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:04):

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China...

Stats
Volumen de hoy	22.99M
Volumen promedio	12.36M
Capitalización de mercado	6.81B
EPS	CNY0.0618 ( 2023-10-24 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	33.38
ATR14	CNY0.0100 (0.19%)

Volumen Correlación

Largo: -0.12 (neutral)

Corto: -0.25 (neutral)

Signal:(37.392) Neutral

Changzhou Qianhong Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Changzhou Qianhong Correlación - Moneda/Commodity

-0.09
( neutral )

-0.40
( neutral )

0.00
( neutral )

0.51
( weak )

Changzhou Qianhong Finanzas

Annual	2023
Ingresos:	CNY1.81B
Beneficio Bruto:	CNY784.94M (43.26 %)
EPS:	CNY0.140

FY	2023
Ingresos:	CNY1.81B
Beneficio Bruto:	CNY784.94M (43.26 %)
EPS:	CNY0.140

FY	2022
Ingresos:	CNY2.30B
Beneficio Bruto:	CNY888.97M (38.59 %)
EPS:	CNY0.250

FY	2021
Ingresos:	CNY1.87B
Beneficio Bruto:	CNY833.63M (44.46 %)
EPS:	CNY0.150

Financial Reports:

No articles found.

Changzhou Qianhong

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.